Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wang Dong

Showing results (61-70 of 252) with videos related to

Pageof 26
Sort By:
Expert Opinion on Therapeutic Targets|March 20, 2013
MicroRNA-21 with therapeutic potential in autoimmune diseasesWang-Dong Xu, Hai-Feng Pan, Jie-Hua Li, et al.
Journal of Separation Science|October 31, 2006
Supercritical CO2 extraction of emodin and physcion from Polygonum cuspidatum and subsequent isolation by semipreparative chromatographyHong-Mei Lu, Wang-Dong Ni, Yi-Zeng Liang, et al.
Clinical Rheumatology|May 26, 2012
Is serum microRNA better specific marker for systemic lupus erythematosus?Man-Man Lu, Rui-Xue Leng, Wang-Dong Xu, et al.
Frontiers in Immunology|August 1, 2022
GDF-15: A Potential Biomarker and Therapeutic Target in Systemic Lupus ErythematosusWang-Dong Xu, Qi Huang, Chan Yang, et al.
Journal of Cellular and Molecular Medicine|October 4, 2019
Insights into IL-29: Emerging role in inflammatory autoimmune diseasesJia-Min Wang, An-Fang Huang, Wang-Dong Xu, et al.
Inflammation|April 27, 2012
Association of MicroRNA-146a with autoimmune diseasesWang-Dong Xu, Man-Man Lu, Hai-Feng Pan, et al.
Clinical Rheumatology|October 6, 2011
Targeting IL-6 promoter polymorphism -174G/C should be dependent on ethnicityWang-Dong Xu, Yu-Jing Zhang, Hai-Feng Pan, et al.
International Journal of Rheumatic Diseases|June 4, 2023
Relationship between SHP2 gene polymorphisms and systemic lupus erythematosus riskRong Li, Ling Zhou, Chan Yang, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|June 9, 2011
Concurrent occurrence of chronic lymphocytic thyroiditis with hypothyroidism and growth hormone deficiency in a Turner's syndrome patientWu Jin, Fa-Xiang Cheng, Mei-Sun Xiao, et al.
International Immunopharmacology|September 30, 2018
Plasma interleukin-38 in patients with rheumatoid arthritisWang-Dong Xu, Lin-Chong Su, Cheng-Song He, et al.
Pageof 26

Showing results (61-70 of 252) with videos related to

Sort By:
Pageof 26
Expert Opinion on Therapeutic Targets|March 20, 2013
MicroRNA-21 with therapeutic potential in autoimmune diseasesWang-Dong Xu, Hai-Feng Pan, Jie-Hua Li, et al.
Journal of Separation Science|October 31, 2006
Supercritical CO2 extraction of emodin and physcion from Polygonum cuspidatum and subsequent isolation by semipreparative chromatographyHong-Mei Lu, Wang-Dong Ni, Yi-Zeng Liang, et al.
Clinical Rheumatology|May 26, 2012
Is serum microRNA better specific marker for systemic lupus erythematosus?Man-Man Lu, Rui-Xue Leng, Wang-Dong Xu, et al.
Frontiers in Immunology|August 1, 2022
GDF-15: A Potential Biomarker and Therapeutic Target in Systemic Lupus ErythematosusWang-Dong Xu, Qi Huang, Chan Yang, et al.
Journal of Cellular and Molecular Medicine|October 4, 2019
Insights into IL-29: Emerging role in inflammatory autoimmune diseasesJia-Min Wang, An-Fang Huang, Wang-Dong Xu, et al.
Inflammation|April 27, 2012
Association of MicroRNA-146a with autoimmune diseasesWang-Dong Xu, Man-Man Lu, Hai-Feng Pan, et al.
Clinical Rheumatology|October 6, 2011
Targeting IL-6 promoter polymorphism -174G/C should be dependent on ethnicityWang-Dong Xu, Yu-Jing Zhang, Hai-Feng Pan, et al.
International Journal of Rheumatic Diseases|June 4, 2023
Relationship between SHP2 gene polymorphisms and systemic lupus erythematosus riskRong Li, Ling Zhou, Chan Yang, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|June 9, 2011
Concurrent occurrence of chronic lymphocytic thyroiditis with hypothyroidism and growth hormone deficiency in a Turner's syndrome patientWu Jin, Fa-Xiang Cheng, Mei-Sun Xiao, et al.
International Immunopharmacology|September 30, 2018
Plasma interleukin-38 in patients with rheumatoid arthritisWang-Dong Xu, Lin-Chong Su, Cheng-Song He, et al.
Pageof 26